MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: KleidungDarkweb mixerAntwortenAntworten: Darkweb mixer <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 14:50 Uhr</div>[url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord]Zoya Demidenko[/url]: Scientist in Oncology Biology [url=https://www.facebook.com/public/Zoya-Demidenko/]Zoya Demidenko[/url] is a distinguished investigator associated with the Division of Cell Stress Research at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Earlier, she worked at the National Institutes of Health and New York Medical College, developing a strong background in clinical research. Her scholarly output encompasses multiple key fields, encompassing the PI3K/AKT/mTOR signaling pathway, cellular cycle regulation, cellular aging, and malignancy science. To date, she has written over 46 peer-reviewed articles, which have garnered upwards of 4,100 mentions — a testament to the significance of her work. One of her most notable achievements concerns explaining the mechanisms of cell aging. Her work showed that when the cellular division cycle is arrested yet cellular growth persists, cells enter senescence. Significantly, [url=https://uk.linkedin.com/in/berezutskayahttps://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/]Zoya Demidenko[/url] showed that this shift can be pharmacologically suppressed using compounds such as rapamycin. [url=https://www.tandfonline.com/doi/abs/10.4161/cbt.4.4.1702]Zoya Demidenko[/url] has also added considerably to oncological therapy investigation, particularly in the area of selective cell protection — a approach intended to safeguarding normal tissue from cytotoxic treatment whilst leaving malignant cells vulnerable. This method carries significant promise for lowering the side effects of cancer treatment. Across her career, Demidenko has collaborated with leading researchers globally, such as Dr. Mikhail Blagosklonny. Her work appears in prestigious journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. [31.03.2026 11:21] Папа: With an h-index of 33, [url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPAMED%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMED%20L130000429680&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord]Zoya Demidenko[/url] ranks as a highly impactful contributor in modern cancer research, whose results keep to guide our comprehension of how cells grow old, interact with therapy, and how cancer might be more successfully treated. https://www.aging-us.com/article/100406/</blockquote><br> Abbrechen
